so are we expecting an anouncement?, page-27

I wouldn't be surprised to see a forward order soon for Lani.

The BARDA office specifically states they can award orders to companies to help them get a product to market even before it is licensed or manufactured. So we can have certainity.

Re this US solicitation. It could be spun as a positive news story at the AGM or in a update.

One thing for sure is we won't see it now until it crops up in GSK quarterly report sometime into the future.

Opportunity missed.